Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.
Investors looking for a reliable dividend and free cash flow grower could do a lot worse than Coca-Cola in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback